跳至主要内容
临床试验/NCT05596942
NCT05596942已完成3 期

Evaluating the Efficacy of Channa Striata in Stabilizing eNOS in Patients With Septic: A Randomized Control Trial.

Universitas Sebelas Maret2 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2021年7月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
42
试验地点
2
主要终点
Endothelial Nitric Oxide Synthase

研究概览

简要总结

Sepsis is an inflammation response produced by the host's immune system, which is agrravated by oxidative stress. One of the adjuvant therapy according to Surviving Sepsis Campaign Guideline is albumin, which has anti-inflammatory and anti-oxidant effects. However, human albumin is quite expensive, and other forms with similar potency and less costs are needed, one of which is Channa striata extract. Therefore, this study is conducted to compare albumin and human albumin, specifically their anti- inflammatory and anti-oxidant properties by assessing the eNOS marker, neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) in patient with sepsis.

详细描述

In summary, this study showed that Channa striata extract has a better outcome in stabilizing eNOS level in patient with sepsis than human albumin 20%, and it has a potential benefit in stabilizing NLR values. However, further studies with a larger sample and a more advanced phase of sepsis are needed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients sepsis who met the qSOFA criteria ≧ 2 [two of which: unconsciousness (Glasgow Coma Scale ≤14)
  • respiratory rate > 22 and systolic blood pressure ≤ 100 mmHg],
  • aged ≧ 18 years
  • admitted to intensive care unit and high care unit at Dr. Moewardi General Hospital

排除标准

  • patients with severe trauma
  • blood loss in stage three or higher
  • stress ulcers
  • a history of nephrotic syndrome
  • refusal to participate

结局指标

主要结局

Endothelial Nitric Oxide Synthase

时间窗: three days after treatment

Measured before and three days after treatment, and the examiners compare the three markers statistically.

次要结局

  • Neutrophil-Lymphocyte Ratio(three days after treatment)
  • Platelet-Lymphocyte Ratio(three days after treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Septian Adi Permana

Intensivist

Universitas Sebelas Maret

研究点 (2)

Loading locations...

相似试验